GEN Exclusives

More »

GEN News Highlights

More »
May 7, 2013

Recipharm, Synthonics Partner to Promote Drug Delivery Tech

  • Recipharm Pharmaceutical Development and Synthonics have entered a dual-promotion agreement through which the former firm’s customers will have full access to the latter company’s metal coordination chemistry, which has been shown to improve drug delivery and absorption. Financial terms of the agreement were not disclosed.

    In a statement, Recipharm general manager Maria Lundberg noted: “The application of Synthonics’ chemistry improves important characteristics such as bioavailability and solubility and thus increases the likelihood that promising molecules will become viable products.”

    Synthonics’ Ken Slepicka, CEO, added that his firm believes its chemistry will integrate well with Recipharm’s existing solutions.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Block That Microbiome Metaphor!

Which way of thinking about the microbiome would best integrate the virome’s contributions?